LegitScript's Peptide Monitoring List Explained

Google's Unapproved Substances policy names one company as its authority on what counts as an unapproved pharmaceutical or supplement: LegitScript. For most peptide brands, LegitScript is a name they encounter only after a disapproval, when they're researching why an ad got flagged. Understanding how the list actually works — before an account runs into it — is far more useful than reverse-engineering it afterward.

This is different from LegitScript certification, which is a formal application process some advertisers pursue proactively. This is about the monitoring and classification work LegitScript does that feeds Google's restricted list in the first place, covered separately in our certification guide.

What LegitScript Actually Is

LegitScript is a monitoring and verification company that platforms — including Google, Meta, and major payment processors — rely on to assess healthcare, pharmaceutical, and supplement advertisers and products against regulatory standards. It isn't a government body and it doesn't have legal enforcement authority; its role is closer to a trusted third-party research and risk-assessment service that platforms use to inform their own policy enforcement decisions.

For the specific "unapproved pharmaceuticals and supplements" list referenced in Google's policy, LegitScript maintains ongoing research and monitoring on products, ingredients, and sellers across the healthcare and supplement space — including the peptide category specifically, where LegitScript has published dedicated research on what it calls "problematic peptides."

How Products End Up Flagged

Based on LegitScript's published research and monitoring methodology, products and sellers tend to get flagged based on a combination of factors rather than any single trigger:

Regulatory status — whether the product has FDA approval (or equivalent) for the use being implied in its marketing
Marketing positioning — whether the product is presented for human consumption, therapeutic use, or performance/cosmetic enhancement, versus strictly research or laboratory use
Regulatory history — whether the compound or specific seller has been the subject of FDA warning letters, import alerts, or similar actions in any major market
Search and sales context — how the product is actually being searched for and sold across e-commerce and social platforms, not just how a single brand's own site presents it

This last point is worth understanding: LegitScript's monitoring isn't limited to reading individual brand websites. It tracks category-wide patterns — how a compound is discussed, sold, and searched for across the broader market — which means a brand can end up affected by category-level classification even with a genuinely compliant, research-only-positioned site.

Flagged vs. Certified: Two Different Relationships With LegitScript

It's worth being precise about the distinction, because the two get conflated often:

Being on the monitoring/restricted list is not something a brand applies for or consents to — it's LegitScript's independent research and classification work, which platforms then use to inform ad review.
LegitScript certification is a formal, paid application process some advertisers pursue proactively (required for certain categories like non-pharmaceutical CBD before applying for Google's CBD Ads Certification) to demonstrate compliance and potentially unlock advertising eligibility in categories that would otherwise be restricted.

There's no published LegitScript certification pathway specifically for peptides today — unlike CBD, where certification unlocks a defined, narrow advertising eligibility. That may change; Google's willingness to build a certification model for CBD (covered in the main Unapproved Substances breakdown) suggests a similar pathway is plausible for peptides if LegitScript and Google formalize one. Brands operating with clean, LegitScript-aligned practices now are best positioned if that happens.

What "LegitScript-Aligned" Actually Means Operationally

Since there's no peptide-specific certification to apply for yet, the practical goal is operating in a way that would hold up against LegitScript's known evaluation criteria, even without formal certification:

Research-use-only positioning maintained consistently across the entire funnel — not just the ad, but the landing page, product descriptions, and reviews, as detailed in our guide to compliant landing page copy
No dosing, administration, or "how to use" content presented for human or animal consumption
Third-party testing and Certificate of Analysis availability, which supports a research/laboratory-use positioning rather than a consumer-product one
Clean regulatory history — no FDA warning letters or similar actions tied to the brand or its specific product formulations

Why This Matters Beyond Just Google Ads

Because LegitScript's monitoring feeds decisions beyond a single platform — payment processors and other ad platforms reference similar risk assessments — a brand's LegitScript risk posture affects more than just Google Ads eligibility. Building compliant operations around this standard has knock-on benefits for payment processing stability and Meta ad account longevity as well, not just Google-specific compliance.

Frequently Asked Questions

Can a brand ask LegitScript why it was flagged?

LegitScript doesn't operate as a public appeals channel for individual brand classifications in the way a platform's own ad review appeal process does. The more direct path is addressing the underlying policy violation through Google's own edit-or-appeal process, covered in the main Unapproved Substances policy guide.

Does removing therapeutic claims guarantee a product comes off any monitoring list?

Not immediately or automatically — LegitScript's monitoring reflects ongoing, category-wide research rather than a real-time per-brand toggle. Consistent, sustained compliant positioning over time is what actually shifts classification, not a single copy edit.

Is LegitScript certification worth pursuing for a peptide brand today?

Since there's no peptide-specific Google certification pathway yet, formal certification mainly matters currently for brands also selling in categories (like CBD) where it directly unlocks eligibility. For pure peptide brands, the higher-leverage move today is operating to the same standard voluntarily.

Does LegitScript's list overlap with the FDA's own warning letter list?

There's meaningful overlap, since FDA regulatory action is one of the factors LegitScript's monitoring considers, but LegitScript's classification work is broader than just FDA warning letters — it also incorporates marketing positioning and search/sales context that the FDA's own list doesn't directly track.

See how a brand with prior policy history rebuilt toward LegitScript-aligned, compliant operations.

Book a free audit →

LegitScript's Peptide Monitoring List Explained: How Google Decides What's 'Unapproved'